医学
急性呼吸窘迫综合征
安慰剂
不利影响
人口
内科学
外科
麻醉
肺
病理
替代医学
环境卫生
作者
Amy L. Lightner,Vikram Sengupta,Sascha Qian,John Ransom,Sam Suzuki,Jae‐Hyun Park,Timothy Melson,Brian Williams,James J. Walsh,Mustafa Awili
出处
期刊:Chest
[Elsevier]
日期:2023-06-24
卷期号:164 (6): 1444-1453
被引量:37
标识
DOI:10.1016/j.chest.2023.06.024
摘要
Bone marrow mesenchymal stem cell (BM-MSC)-derived extracellular vesicles (ExoFlo) convey the immunomodulatory and regenerative properties of intact BM-MSCs. This study aimed to determine the safety and efficacy of ExoFlo as treatment for moderate to severe ARDS in patients with severe COVID-19.
科研通智能强力驱动
Strongly Powered by AbleSci AI